HHS: FDA's Nonprescription Drug Plan Key To Drug Cost-Cutting Agenda

HHS plays up FDA's emerging plan to boost the availability of nonprescription drugs by letting consumers use mobile apps to select drugs that up to now have only been available by prescription as a key part of the Trump administration's plan to lower drug prices. HHS' fall agenda for regulations lists “Tackling the High Cost of Prescription Drugs” among its priorities for 2019. To meet that priority, HHS plays up FDA's upcoming rule aimed at boosting the availability of nonprescription...